Rafferty Asset Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $658K | Sell |
91,662
-76,013
| -45% | -$546K | ﹤0.01% | 833 |
|
|
2025
Q1 | $1M | Buy |
167,675
+6,802
| +4% | +$40.7K | ﹤0.01% | 739 |
|
|
2024
Q4 | $1.25M | Buy |
160,873
+47,187
| +42% | +$368K | ﹤0.01% | 747 |
|
|
2024
Q3 | $1.23M | Sell |
113,686
-70,277
| -38% | -$759K | ﹤0.01% | 759 |
|
|
2024
Q2 | $1.55M | Sell |
183,963
-520,897
| -74% | -$4.39M | 0.01% | 707 |
|
|
2024
Q1 | $4.74M | Buy |
704,860
+416,189
| +144% | +$2.8M | 0.02% | 482 |
|
|
2023
Q4 | $1.7M | Buy |
288,671
+96,894
| +51% | +$570K | 0.01% | 715 |
|
|
2023
Q3 | $1.87M | Sell |
191,777
-14,366
| -7% | -$140K | 0.01% | 626 |
|
|
2023
Q2 | $2.44M | Sell |
206,143
-36,026
| -15% | -$427K | 0.01% | 590 |
|
|
2023
Q1 | $2.61M | Sell |
242,169
-81,718
| -25% | -$882K | 0.02% | 534 |
|
|
2022
Q4 | $3.74M | Buy |
323,887
+114,511
| +55% | +$1.32M | 0.03% | 439 |
|
|
2022
Q3 | $3.12M | Buy |
+209,376
| New | +$3.12M | 0.03% | 409 |
|